rPSGL-Ig for Improvement of Early Liver Allograft Function: A Double-Blind, Placebo-Controlled, Single-Center Phase II Study†
Open Access
- 14 March 2011
- journal article
- research article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 11 (4), 786-797
- https://doi.org/10.1111/j.1600-6143.2011.03441.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Primary Graft Dysfunction in Lung TransplantationSeminars in Respiratory and Critical Care Medicine, 2006
- Use of Extended Criteria Livers Decreases Wait Time for Liver Transplantation Without Adversely Impacting Posttransplant SurvivalAnnals of Surgery, 2006
- Ischemia and Reperfusion Injury in Liver TransplantationTransplantation Proceedings, 2005
- The utility of marginal donors in liver transplantationLiver Transplantation, 2003
- P‐Selectin Glycoprotein Ligand‐1 (rPSGL‐Ig)‐Mediated Blockade of CD62 Selectin Molecules Protects Rat Steatotic Liver Grafts from Ischemia/Reperfusion InjuryAmerican Journal of Transplantation, 2002
- Influence of Initial Antigen-Independent Events on Acute Allograft Rejection: Inhibition by a Soluble P-Selectin Ligand and Low-Dose Cyclosporine in CombinationTransplantation Proceedings, 1998
- Reduction of Hepatic Ischemia/Reperfusion Injury by a Soluble P-Selectin Glycoprotein Ligand-1Annals of Surgery, 1998
- The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand.JCI Insight, 1997
- ISCHEMIC ACUTE TUBULAR NECROSIS INDUCES AN EXTENSIVE LOCAL CYTOKINE RESPONSETransplantation, 1995
- Policies in Europe on "marginal quality" donor liversThe Lancet, 1994